Zoledronic Acid (ZA) Therapy in the Treatment of Patients with Paget's Disease of Bone (PD) Resistant to Prior Bisphosphonate Therapy or with an Unsustained Response of One Year or Less.
Phase of Trial: Phase III
Latest Information Update: 21 Apr 2014
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Osteitis deformans
- Focus Therapeutic Use
- 21 Apr 2014 New trial record